Breaking News

Paratek Achieves Milestone Creating U.S. Mfg. Supply Chain for NUZYRA

NUZYRA tablets manufactured in the U.S. represents the first step to creating an end-to-end U.S. supply chain for the antibiotic under BARDA contract.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Paratek Pharmaceuticals, Inc. announced the commercial availability of U.S.-produced NUZYRA (omadacycline) tablets. This milestone follows a successful technology transfer by Paratek and its tablet manufacturing partners in the U.S. and Europe.   NUZYRA is the company’s broad-spectrum, novel antibiotic available in both intravenous and oral formulations.   Onshoring of the manufacturing process for the tablets is the first completed step in the technology transfer process, with the active ph...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters